The company's principal activity is to develop and market acute care and critical care hospital, specialty pharmaceutical and related healthcare products. The products of the company are glofil-125, inulin, ethamolin and dermaflo. Glofil and inulin are two injectable drugs to assess kidney function and its treatment. Ethamolin is an injectable drug to treat bleeding esophageal varices. Nutramax products are topical triple antibiotic wound care products. The customers of the company include large drug wholesalers and distributors and certain hospitals and treatment centers. In Jun 2003, the group acquired nascobal(R) an fda approved nasal gel formulation of cyanocobalamin usp from nastech.
